510 related articles for article (PubMed ID: 10194379)
1. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
5. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.
Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH
FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
Nieman MT
Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
[TBL] [Abstract][Full Text] [Related]
7. Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.
Al-Ani B; Hollenberg MD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1120-8. PubMed ID: 12604689
[TBL] [Abstract][Full Text] [Related]
8. Characterization of plasmin-induced platelet aggregation.
Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.
Mao Y; Jin J; Daniel JL; Kunapuli SP
Platelets; 2009 May; 20(3):191-8. PubMed ID: 19437337
[TBL] [Abstract][Full Text] [Related]
10. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
11. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
13. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
Altrogge LM; Monard D
Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
Burke FM; Warnock M; Schmaier AH; Mosberg HI
Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel 33-kDa Ser/Thr kinase that phosphorylates the cytoplasmic tail of protease-activated receptor 1 (thrombin receptor) in human platelets.
Ido M; Hayashi T; Gabazza EC; Suzuki K
Thromb Haemost; 2000 Apr; 83(4):617-21. PubMed ID: 10780327
[TBL] [Abstract][Full Text] [Related]
18. Identification of thrombin receptors in rat brain capillary endothelial cells.
Bartha K; Dömötör E; Lanza F; Adam-Vizi V; Machovich R
J Cereb Blood Flow Metab; 2000 Jan; 20(1):175-82. PubMed ID: 10616806
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM
Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482
[TBL] [Abstract][Full Text] [Related]
20. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
